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Abstract: Equine recurrent uveitis (ERU) causes painful inflammatory attacks and oftentimes blind-
ness in the affected eyes. The disease is considered a late sequela of systemic leptospirosis. The most
effective therapy is the surgical removal of the vitreous (vitrectomy), which is not only therapeutic,
but provides vitreous material that can be assessed diagnostically. For example, the lipL32 gene,
culturable Leptospira spp., and anti-Leptospira antibodies have all been detected in vitreous samples
obtained from eyes with chronic ERU. Despite this clear evidence of leptospiral involvement, the
systemic administration of antibiotics in infected horses is ineffective at resolving ERU. This syn-
drome of chronic recurrent inflammation, which is unresponsive to antibiotic therapy, combined with
apparent bacteria evading the immune response, is consistent with a biofilm-associated infection.
The purpose of this study, therefore, was to detect the in vivo biofilm formation of Leptospira spp.
in vitreous samples collected during vitrectomy and examined using a Warthin-Starry silver stain
and immunohistochemistry. All known steps of biofilm formation were visualized in these samples,
including individual Leptospira spp., leptospiral microcolonies and dense roundish accumulations of
Leptospira spp. In many instances spirochetes were surrounded by an extracellular substance. Taken
together, data from the present study show that ERU is a biofilm-associated intraocular leptospiral
infection, which best explains the typical clinical course.
Keywords: in vivo biofilm formation; biofilm infection; Leptospira spp.; immune tolerance; antibiotic
tolerance; equine recurrent uveitis (ERU); vitreous humor; immunohistochemistry; Warthin-Starry
silver stain
1. Introduction
Biofilm-associated infections are characterized by persistent and progressive disease
in which the inflammatory response surrounding the biofilm plays a significant role [1,2].
Four steps of biofilm formation have been described: (1) single bacteria; (2) the formation of
microcolonies; (3) a mature biofilm; and (4) the breakup of biofilm and release of planktonic
bacteria [3]. In vitro biofilm formation has been described in detail for Leptospira spp. [4–6]
and there is evidence of in vivo biofilm formation following experimental infections [7,8].
In horses, recurrent uveitis occurs at unpredictable intervals over a period of many
years and usually leads to blindness despite intensive conservative therapy [9–11]. Both
eyes are affected in about 25–50% of horses [12,13]. ERU affects up to 10% of all horses in
Europe [14–16] and up to 25% in the US [17].
In European horses without a leopard coat pattern, the most effective method to
prevent further episodes of uveitis and thereby preserve vision is vitrectomy [10,18–21].
After a properly performed vitrectomy, which has been routinely performed for more
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than 30 years in horses with ERU, the control of inflammation is seen in 90–97% of
horses [10,13,21–24]. By contrast, uveitis in horses with a leopard coat pattern mani-
fests differently. Affected horses typically do not appear to be as painful. Intraocular
leptospiral infection is rarely confirmed suggesting that the etiology and pathogenesis are
different from that seen in horses without a leopard coat pattern [25].
The vitreous removed during vitrectomy are intensely investigated in the hope of
better determining etiology, pathogenesis and treatment strategies for ERU. Many of these
studies have suggested an association between leptospiral infection and ERU [26–31]. For
example, anti-Leptospira antibodies are regularly detected in vitreous material obtained
during vitrectomies [13,15,21,32–41]. These antibodies are detected using the micro agglu-
tination test (MAT), and various enzyme-linked immunosorbent assays (ELISA) [42,43].
In other studies, Leptospira spp. are cultured and anti-Leptospira antibodies are detected
in the same vitreous samples [13,21,32,35,39,44–46]. In addition, lipL32 gene or 16S-rRNA
are detected by a polymerase chain reaction (PCR) in up to 70% of intraocular samples
collected from affected horses [32,39,43–45].
Finally, scanning electron microscopy is used to reliably detect Leptospira spp. in
vitreous material from equine eyes affected with recurrent uveitis. The leptospiral organ-
isms were surrounded by a homogeneous granular layer, which has not been seen in
Leptospira spp. cultured in vitro (using standard World Health Organization (WHO)
strains) [47,48].
In addition to direct evidence of the leptospiral infection of vitreous samples from
eyes affected with ERU, evidence of autoimmunity also exists [49]. However, Prof. Deeg’s
research group [50] performed all investigations using vitreous samples, from which lep-
tospiral infections were also regularly detected [13,21,39,41–43,46]. Furthermore, while
vitrectomy removes the vitreous material, potential autoantigens from other tissues
—especially the lens and retina—remain in the eye [18,39] which contradicts the idea
of autoimmunity [39,51].
Taken together, data from numerous studies using specimens from eyes affected
with ERU support the hypothesis that ERU is triggered and perpetuated by the chronic
infection of the vitreous cavity with Leptospira spp., and that this may be eliminated by
vitrectomy [13,21,32,33,36,37,39,44]. However, systemic antibiotic therapy has not been
successful at controlling the inflammation seen in ERU.
The vitreous body consists of 98–99% water, contains collagen fibrils and represents
a 28 mL immunological niche in horses [13,39,52–54]. These are optimal conditions for
the biofilm production of the Leptospira spp. [55]. In addition, ERU exhibits all of the
characteristics of a biofilm infection: chronicity, inflammation, and a high tolerance to both
antibiotics [46] and the body’s immune defenses. The aim of this ex vivo study was to
demonstrate, using Warthin-Starry silver stain and immunohistochemistry, the biofilm
formation by Leptospira spp. in vitreous material obtained during vitrectomies performed
on horses with ERU.
2. Materials and Methods
2.1. Positive Controls
Culture Leptospira spp. (WHO strains) were spread on microscope slides (Thermo Sci-
entific Superfrost Ultra Plus; Menzel B.V. & Co.KG, Braunschweig, Germany) and allowed
to dry overnight. Warthin-Starry silver stain and immunohistochemistry were then per-
formed. The leptospiral serovars used for this study (Grippotyphosa, Bratislava, Australis,
Autumnalis, Icterohaemorrhagiae and Pomona) were obtained from an accredited labora-
tory (State Office for Health and Food Safety, Oberschleissheim, Germany; accreditation
DIN EN ISO 17025, Reg. No.: D-PL-19082-02-00).
2.2. Sample Selection
After careful case selection of horses whose history and clinical findings indicated
Leptospira-induced uveitis [21], vitrectomy was performed as a therapeutic procedure at the
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Equine Clinic of Ludwig-Maximilians-University in Munich, Germany. All vitrectomies
were performed as previously described [18]. At the beginning of surgery, about 3 mL
of undiluted vitreous humor was obtained routinely from the suction line. In order to
confirm intraocular leptospiral infection, an aliquot of each sample was sent to an external
laboratory for MAT and PCR (Society for Innovative Veterinary Diagnostics, Seelze-Letter,
German accreditation authority: D-PL-18303-02-00). Additionally, some vitreous humor
was spread on microscope slides and allowed to dry overnight. Approximately 10 smears
were obtained from each vitreous sample from ERU eyes. Only samples with a positive
PCR result were used for the examinations (Table 1).
Table 1. Signalment of equine patients, clinical diagnosis and laboratory findings of vitreous samples.
Sample Signalment Clinical Diagnosis lipL32 Gene PCRResult (Ct Value)
Vitreal Leptospiral
Antibody Titer (MAT) 1
1 4-year-old warmblood gelding ERU Positive (Ct 37) Grippotyphosa 1:3200
2 8-year-old Icelandic horse mare ERU Positive (Ct 40) Grippotyphosa 1:400
3 7-year-old Friesian mare ERU Positive (Ct 29) Grippotyphosa 1:3200
4 7-year-old warmblood mare ERU Positive (Ct 37) Grippotyphosa 1:800
5 15-year-old warmblood gelding ERU Positive (Ct 38) Grippotyphosa 1:400
6 10-year-old Friesian gelding ERU Positive (Ct 30) Altoduro 1:400
7 6-year-old warmblood mare ERU Positive (Ct 32) Grippotyphosa 1:3200
8 7-year-old warmblood mare ERU Positive (Ct 35) Grippotyphosa 1:3200
9 4-year-old thoroughbred gelding ERU Positive (Ct 33) Grippotyphosa 1:3200
10 6-year-old warmblood mare ERU Positive (Ct 34) Grippotyphosa 1:3200
11 5-year-old Icelandichorse gelding ERU Positive (Ct 33) Altoduro 1:100
12 5-year-old warmblood stallion ERU Positive (Ct 33) Grippotyphosa 1:3200
13 5-year-old warmblood gelding ERU Positive (Ct 38) Grippotyphosa 1:3200
14 10-year-old warmblood gelding ERU Positive (Ct 39) Grippotyphosa 1:800
15 8-year-old warmblood mare ERU Positive (Ct 38) Grippotyphosa 1:800
16 5-year-old warmblood mare ERU Positive (Ct 35) Grippotyphosa 1:3200
17 8-year-old warmblood gelding ERU Positive (Ct 35) Grippotyphosa 1:200
18 5-year-old warmblood gelding ERU Positive (Ct 32) Grippotyphosa 1:200
19 5-year-old warmblood mare ERU Positive (Ct 33) Grippotyphosa 1:1600
20 4-year-old warmblood gelding ERU Positive (Ct 33) Grippotyphosa 1:100
21 3-year-old warmblood mare ERU Positive (Ct 38) Negative
22 10-year-old warmblood gelding ERU Positive (Ct 36) Grippotyphosa 1:3200
23 6-year-old warmblood mare ERU Positive (Ct 36) Grippotyphosa 1:3200
24 7-year-old purebredSpanish stallion ERU Positive (Ct 39) Grippotyphosa 1:3200
25 10-year-old purebredSpanish mare ERU Positive (Ct 39) Australis 1:3200
26 15-year-old warmblood mare ERU Positive (Ct 39) Grippotyphosa 1:3200
27 8-year-old Welsh pony mare ERU Positive (Ct 32) Grippotyphosa 1:3200
28 7-year-old warmblood gelding ERU Positive (Ct 29) Pomona 1:3200
29 12-year-old warmblood gelding ERU Positive (Ct 35) Grippotyphosa 1:3200
30 8-year-old warmblood gelding Normal 2 Negative Negative
31 23-year-old Haflinger mare Normal 2 Negative Negative
32 17-year-old warmblood gelding Normal 2 Negative Negative
1 Only the serovar with the highest titer is shown. 2 Clinical examinations revealed no signs of ERU.
2.3. Negative Controls
For subsequent analysis using Warthin-Starry silver stain and immunohistochemistry,
vitreous humor samples from clinically normal eyes in which anti-Leptospira antibodies
could not be detected by MAT and the lipL32 gene was not detected after 40 cycles of qPCR
were used as controls (Table 1).
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2.4. Warthin-Starry Silver Stain
A modified Warthin-Starry [56] protocol was used to identify leptospiral organisms in
vitreous humor samples. The slides were first incubated in 1% silver nitrate solution (Fa.
Morphisto, Offenbach a. M., Germany) for half an hour at 60 ◦C in the dark and then briefly
rinsed in distilled water. A solution containing hydroquinone (“silver enhancer stock
solution B” Fa. Morphisto, Offenbach a. M., Germany) was used to reduce the bound silver
to a visible metallic form. Developer solution was prepared and preheated to 55–60 ◦C in
a water bath and afterwards placed onto the slides for 2–3 min. The developing process
was performed under visual control. The slides were briefly drained and rinsed twice for
1 min. each in warm distilled water (55–60 ◦C), incubated with 5% sodium thiosulfate (Fa.
Morphisto, Offenbach a. M., Germany) at room temperature, and then rinsed for 3 min.
under running tap water. Finally, the smears were covered with eukitt® (Fa. Sigma-Aldrich
Chemie GmbH, Taufkirchen, Germany) for microscopic evaluation.
2.5. Immunohistochemistry
The slides were pulled through the flame twice for heat fixation. All washing steps
were done with phosphate buffered saline (PBS) (pH 7.4), and all incubation steps took
place at room temperature. After washing once for 4 min, non-specific binding was
reduced by bathing in regular protein block (Dako Protein-Block-Serum-Free, Dako GmbH,
Jena, Germany) for 5 min. The slides were then incubated for one hour with a specific
antibody (anti-Leptospira rabbit antiserum from the OIE and National Collaborating Centre
for Reference and Research on Leptospirosis, Academic Medical Center, Department of
Medical Microbiology, University of Amsterdam) diluted 1:5120 in Dako Diluent, Dako
GmbH, Jena, Germany). After washing twice for 1 min each time, slides were incubated for
30 min. with secondary antibody (Biotinylated anti-rabbit IgG, Biozol, Eching, Germany)
diluted 1:300. After washing twice more, slides were incubated with horseradish peroxidase
conjugate (Streptavidin-HRP, Leika, Germany) for 20 min. After the last wash, slides were
incubated for 5 min in hydrogen peroxide solution (DAB, Dako GmbH, Jena, Germany),
and washed with PBS and tap water. After dehydrating in alcohol (70% alcohol, 96%
alcohol, 2x isopropanol, 2x xylene) slides were covered with eukitt® (Fa. Sigma-Aldrich
Chemie GmbH, Taufkirchen, Germany) for microscopic evaluation. Cultured Leptospira
spp. from an accredited leptospiral laboratory were served as positive tissue controls (State
Office for Health and Food Safety, Oberschleissheim, Germany; accreditation DIN EN ISO
17025, Reg.-Nr.: D-PL-19082-02-00). Samples incubated without primary antibodies formed
system controls. Vitreous samples from clinically normal eyes served as negative tissue
controls (Table 1).
2.6. Microscopy Images Acquisition
The evaluation was performed with a light microscope (Leica DM 5000B) connected
to a digital color camera (Leica DFC 450 C). Samples were routinely screened first using
the 10×, then the 40×, and finally the 100× objective (with oil). Representative areas were
photographed.
The results are aligned according to the steps of biofilm formation already described
by Jamal et al. [3]:
1. Initial contact/attachment to the surface: Adhesion and cohesion; the attachment to a
surface, as well as the attachment of bacteria to each other.
2. Microcolony formation: After stable attachment to a surface or other bacteria, the
bacteria began to multiply by cell division, as well as forming extracellular polymeric
substances (EPS), which led to the formation of microcolonies.
3. Maturation and architecture: EPS are the main components of the biofilm. Cell density
in the biofilm is controlled by intercellular signaling and cell-to-cell communication
(quorum sensing). This leads to the production of EPS and thus to a three-dimensional
dense biofilm structure.
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4. Detachment/dispersion of biofilm: Multiplication of bacteria in the biofilm results in
further spreading and reattachment to a surface or other bacteria.
3. Results
Twenty-nine PCR-positive vitreous samples were selected from equine eyes clinically
diagnosed with ERU (Table 1, samples 1–29) to attempt to visualize the different steps
of biofilm formation. As a control, three vitreous samples were obtained from clinically
healthy eyes (Table 1, samples 30–32). The vitreal leptospiral antibody titer test was positive
in 28 (96.6%) of 29 samples. The negative MAT result of sample no. 21 could be due to the
fact that either no antibodies had yet been formed by the time the sample was taken, or
antibodies were no longer detectable, or the overall immune response was so low that it
was not possible to detect antibodies by MAT.
3.1. Positive Controls
The cultured Leptospira spp. appear as single thin corkscrew-shaped organisms in both
Warthin-Starry silver stain and immunohistochemistry, as is typical for this genus. The
length of the single bacteria is approximately 10 to 20 µm and they have a very thin diameter
of approximately 0.5 µm. They have hooked ends on one or both sides, which distinguishes
them from other spirochaetes. The individual bacteria are sometimes completely elongated,
generally curved, or have more complex S, U or L shapes. Sometimes one or more bacteria
lie side by side, on top of each other, or are intertwined. However, the individual bacterium
is always clearly distinguishable. In some cases, the corkscrew-like coiling can be clearly
seen as small bumps on the thin, filamentous leptospiral body (Figure 1). No evidence of




Figure 1. Smears from culture Leptospira spp. (A): Serovar Grippotyphosa, Warthin-Starry stain.
(B): Serovar Grippotyphosa, immunohistochemistry. (C): Serovar Australis, Warthin-Starry stain.
(D): Serovar Australis, immunohistochemistry.
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3.2. Samples from ERU Eyes
Leptospira spp. could not be detected on every slide examined. This can be explained
by the small sample volume and the inhomogeneous vitreous matrix. Nevertheless, at least
one of the three steps of biofilm formation could be found in smears of each vitreous sample
using both staining methods. In addition, it was possible to show all three steps of biofilm
formation on the same slides. The evaluation of the slides was extremely time-consuming.
3.3. Steps in Biofilm Formation
1. Initial contact/attachment to the surface:
Both the Warthin-Starry silver stain (Figure 2A) and immunohistochemistry
(Figure 2B) revealed solitary dark brown stained Leptospira spp. Individual Leptospira
spp. showed the characteristics of spiral coils and hooked ends as described above, while
two or more organisms were sometimes seen lying next to or crossing each other. Re-
gardless, individual organisms could always be distinguished from each other easily
(Figure 2A,B).
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Figure 2. Smears from vitreous body samples from horses diagnosed with ERU. (A) Solitary Lep-
tospira spp., Warthin-Starry stain. (B) Solitary Leptospira spp., immunohistochemistry. (C) Leptospiral
aggregates and surrounding matrix, Warthin-Starry stain. (D) Leptospiral aggregates and surround-
ing matrix, immunohistochemistry. (E) Dense roundish conglomerates composed of Leptospira spp.
and matrix, Warthin-Starry stain. (F) Dense roundish conglomerates composed of Leptospira spp. and
matrix, immunohistochemistry. (Arrows: dense round structures on the Leptospira spp.).
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Overall, the Leptospira spp. from the vitreous samples of horses affected with ERU
appear somewhat thicker and less delicate than the cultured Leptospira spp. (Figure 1). Lep-
tospira spp. from vitreous samples show a significant increase in thickness (approximately
1–2 µm) especially in the Warthin-Starry silver stain, where their shape becomes more
blurred. In some cases, Leptospira spp. are covered by granular structures. In addition,
a stronger staining of the leptospiral environment can be seen, which is represented by
the light brown (IHC) or dark brown (Warthin-Starry silver stain) stained and partially
granulated matrix (Figure 2).
2. Microcolony formation:
Individual, well-defined Leptospira spp. and dense variably sized aggregates of Lep-
tospira spp. were seen using either silver stain or the antibody against Grippotyphosa
(Figure 2C,D). The aggregates were round, oval or polygonal with some having “frayed”
borders consisting of individual intact or fragmental Leptospira spp. (Figure 2C,D). A vari-
ably intensely positive, immunohistochemical, reacting homogeneous matrix was evident
between the densely packed Leptospira aggregates (Figure 2D). Similarly, in the Warthin-
Starry silver stain, a slightly weaker stained inhomogeneous granular matrix appeared
between the denser bacteria, which was strongly stained (Figure 2C).
3. Maturation and architecture:
The leptospiral aggregates and the secreted substance condensed such that individual
Leptospira spp. could not be distinguished from each other (Figure 2E,F). These condensed
structures were approximately round with a diameter of approximately 5 to 20 µm and
were clearly distinguishable from the surroundings. Occasionally, individual Leptospira spp.
protruding from the aggregates could be identified by their characteristic corkscrew-like
coiling and/or hooked ends (Figure 2E,F).
3.4. Negative Controls
Vitreous samples from clinically healthy equine eyes were negative for both leptospiral
PCR and leptospiral antibody titers (MAT) (Table 1, sample 30–32). Neither Leptospira spp.
nor evidence of biofilm formation were detected in these samples using Warthin-Starry
silver stain or immunohistochemistry.
4. Discussion
Descriptions of in vitro biofilm formation have been published for Borrelia spp. [57]
and Leptospira spp. [5,6]. In vivo biofilm formation is described in humans with lym-
phoma [58] or Lyme borreliosis [59]. Although the in vivo biofilm formation by
Leptospira spp. has been suspected in renal tubules [5,60], to date it is found exclusively
after experimental infections [7,8]. The attachment of bacteria to surfaces is considered
to be of great importance for biofilm formation. However, pathogens can also attach to
each other and can form a biofilm without being attached to another surface or host tissue.
A biofilm can occur in liquid or mucous media [2,3,61–63]. The mechanical or surgical
removal of the biofilm is described as the best way to eliminate chronic biofilm-associated
infections [64–66].
To the authors’ knowledge, the present study was the first to detect Leptospira spp.
and different steps of biofilm formation in vitreous samples of horses with ERU using im-
munohistochemical analysis and Warthin-Starry silver staining. Previously, IHC analyses
were performed exclusively on fixed tissue sections. In addition, MAT, ELISA, fluorescent
antibody tests, dark-field microscopy, culture, PCR, and histopathology with special stains
are all used to identify anti-Leptospira antibodies, Leptospira spp., or leptospiral DNA in
the tissues or body fluids of dogs [67–69]. Whereas, in hamsters, the leptospiral injury of
the kidney has been investigated using culture, histology, MAT, serum creatinine concen-
trations, and immunofluorescent staining [70]. In the present study, tissue sections are
not available. Rather, the undiluted vitreous samples of 2–3 mL per patient were utilized.
This necessitated the development of a method that does not notably alter spirochete
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morphology but in which the organisms are reliably stained. Two different techniques are
used for this purpose:
Silver plating [71–73] is considered a reliable technique for the demonstration of
spirochetes. Difficulties with this method arise, however, when only a few organisms are
present, since leptospiral fragments cannot be detected. Therefore, in the present study,
we used a rabbit anti-Leptospira antibody and a modified immunohistochemical protocol
as a supplemental method for the morphological visualization of Leptospira spp. and of
the various steps of biofilm formation. IHC has been previously described as a specific
detection method of leptospiral antigens in various tissue samples and species and for
studying biofilm formation in vivo of pathogenic Leptospira spp. [74–76].
To the authors’ knowledge, this is also the first morphological description of the steps
of biofilm formation of Leptospira spp. in vivo; however, the same steps of biofilm formation
described for bacteria in general [3,64,77] were demonstrated here using Warthin-Starry
silver stain and IHC. In addition, the morphological characteristics of in vivo biofilm forma-
tion demonstrated in the present study were similar to those shown in vitro for saprophytic
and pathogenic Leptospira spp., using transmission electron microscopic studies [5]. In-
dividual Leptospira spp., cell aggregates, microcolonies, and, ultimately, mature biofilm
structures were all visualized in the present study. In accordance with Ristow et al. [5],
bacterial colonies in the mature biofilm were densely packed, surrounded by an amorphous
mass, and formed an approximately round structure.
In vitro, Leptospira spp. are capable of biofilm formation within a few days [5,6] with
the first stage requiring cohesion (binding of bacteria to each other) and adhesion (binding
of bacteria to a surface) [78,79]. After individual bacteria assemble into microcolonies they
surround themselves with an amorphous polymer matrix [62], with the mature biofilm
structure taking on a round shape and individual Leptospira spp. no longer recognizable [6].
Because the polymer matrix of the biofilm is produced by the bacteria themselves it is
detectable using antibodies directed against Leptospira spp. In the present study, bacterial
cohesion was morphologically evident by silver staining and IHC labeling; however, other
structures of the vitreous (collagen fibrils, cells, and inflammatory products formed as a
result of uveitis) were not stained. IHC was previously described as a specific detection
method of leptospiral antigens in various tissue samples and species and for studying
biofilm formation in vivo of pathogenic Leptospira spp. [74–76].
Canine renal tissues were stained with specific leptospiral antigens and were further
investigated with the silver staining method. Therefore, the results of Wild et al. [80] show
that immunohistochemistry is a helpful method in the diagnosis of canine leptospirosis.
Additionally, immunohistochemistry and the Warthin-Starry stain showed that pathogenic
Leptospira spp. were present on the surface of pulmonary epithelium [81].
The slides on which no Leptospira spp. were found can be explained, among other
things, by the fact that the vitreous is very inhomogeneous, consists of 98% water, and only
about 1 mL of the vitreous material is available undiluted for smears. All other studies
detecting Leptospira spp. use tissue guided by other structures and serial sections are
available [76,81].
Six criteria have been established to describe biofilm-associated infections: four orig-
inal criteria by Parsek and Singh [82], and two additional criteria by Hall-Stoodley and
Stoodley [83]. It is worthwhile to consider each of these criteria individually as they relate
to observations in the present study.
1. Infecting bacteria are bound to a substrate or a surface [82]:
Although attachment of Leptospira spp. to a surface is not demonstrated in the present
study, this is not expected since the vitreous body is composed largely of water. In addition,
biofilm formation without attachment to a surface has been described. It is likely in
these situations that this occurs via the cohesion of bacteria to each other. For example, a
Pseudomonas aeruginosa biofilm without surface attachment is found in tracheobronchial
secretions [2,3,61,62]. It is also possible for bacterial adhesion to occur at a microscopic
(cellular or subcellular) rather than tissue level, for example, in the vitreous cavity to
Microorganisms 2021, 9, 1915 9 of 14
collagen fibrils [53,54] present in the normal and inflamed vitreous, or to a serum amyloid
A [84,85] present in inflamed vitreous. In aquatic environments, plant fibers represent
comparable surfaces on which Leptospira spp. biofilm formation can begin [86]. Regardless
of whether or not fibrils initially serve as surfaces for the attachment in the vitreous cavity,
leptospiral biofilm formation may additionally occur freely in aqueous vitreous phases.
2. The direct examination of infected tissue reveals bacteria living in cell aggregates or
microcolonies surrounded by extracellular matrix [82]:
Immunohistochemical examination of vitreous samples from eyes with ERU in the
present study reveals various steps of biofilm formation, including cell aggregates and
microcolonies. In each case, bacteria are surrounded by an extracellular matrix that is
also immunopositive. This extracellular matrix surrounding Leptospira spp. is also found
ultrastructurally in vitreous samples from equine eyes affected with ERU [47,48].
3. Biofilm-associated infections are generally confined to a specific location (although
bacterial dissemination may occur, it is considered a secondary phenomenon) [82]:
Leptospiral infection in horses with ERU is an intraocular infection exclusively de-
tectable in the aqueous humor and vitreous samples [13,39]. Since both leptospiral culture
and PCR are positive more frequently with vitreous material than with the aqueous humor,
there is much to suggest that Leptospira spp. persist in the vitreous cavity [13,39]. The
detection of Leptospira spp. or its DNA within the aqueous humor may represent organ-
isms that have entered the anterior chamber of the eye from the vitreous humor between
the zonular fibers of the lens since there is limited exchange of water between the two
humors. By contrast, the persistence of Leptospira spp. in the lens or the highly vascular
uvea seems unlikely. Similarly, there is no evidence for the dissemination of Leptospira spp.
from the eye to other systemic sites. Further supporting the hypothesis that leptospiral
infection is limited to the vitreous is the knowledge that the vitrectomy reliably eliminates
ERU [13,18,21,39]. After vitrectomies, intraocular antibody titers decrease continuously
and after one year MAT becomes negative, and Leptospira spp. cannot be cultured and
neither the lipL32 gene nor 16S rRNA can be detected by PCR in intraocular samples [39].
4. Biofilm-associated infections are impossible or difficult to eliminate using antibiotics,
to which the responsible organisms are sensitive when in their planktonic or free-
living state [82]:
The systemic administration of antibiotics effective against Leptospira spp. are ineffec-
tive at controlling ERU. Despite vitreal enrofloxacin concentrations above the minimum
inhibitory concentrations (MIC) for Leptospira spp., these organisms could be cultured
from vitreous material [46]. In fact, cultures were only slightly less frequently positive in
enrofloxacin-treated (30%) than in untreated (54%) horses. Leptospira spp. have also been
cultured in some cases from the irrigation fluid collected during vitrectomies, in which the
removed vitreous material is diluted approximately 10-fold and exposed to 0.8 mg/mL of
gentamicin [40,87]—approximately 100-fold higher than the MIC [88].
5. No organism can be cultured despite a strong presumption of infection with the
pathogen of interest [83]:
Conditions for the culture of Leptospira spp. were demanding. Even with the optimal
collection techniques of undiluted vitreous samples and the immediate sterile inoculation
into a transport medium, Leptospira spp. were cultured from only 53% of the samples [13,39].
This percentage is comparatively high. However, the positive culture result was often
obtained only after several months. In other studies, Leptospira spp. could be cultured
in only a small percentage of the vitreous samples examined [32,35,44]. Many other
investigators failed to culture Leptospira spp. [26,31,89,90], which led to the hypothesis that
ERU is an autoimmune disease [90–92].
6. Ineffective immune response as evidenced by bacterial aggregates surrounded by
inflammatory cells within host tissue [83]:
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The vitreous body is 98%–99% water, but also contains collagen fibrils, occasional
cells, and hyaluronic acid [52–54]. As such, vitreous material is not a typical “tissue”
but rather a somewhat heterogeneous viscous liquid. The histological preparations of
vitreous specimens often do not show stainable Leptospira spp. Therefore, an inflammatory
reaction surrounding the bacterial aggregates is not present in the same form seen in other
tissues. However, when considering the closest vascularized tissue—the uvea, an increase
in inflammatory cells is noted, especially in the ciliary body [93,94], but also within the
vitreous cavity [47,48,53,95]. Despite high antibody titers and the presence of macrophages
within the vitreous, vitreal Leptospira spp. are not eliminated. On the contrary, high vitreal
anti-Leptospira antibody titers increase the probability of successful leptospiral culture from
that sample [13,39,47]. If, as suspected, the dense round structures seen in the images by
Brandes et al. [47] are biofilm, it seems possible that these structures may not be completely
eliminated by macrophages.
Taking into account that the vitreous material as a heterogeneous viscous liquid
cannot be equated with other tissues in every point, ERU fulfills all criteria described for
biofilm-associated infections.
Neutrophil extracellular traps (NETs) have also been detected in vitreous samples
from eyes affected by ERU [96]. Bacterial infections can initiate the formation of NETs,
particularly when phagocytosis fails to eliminate the pathogen. Biofilms appear to be a
particularly notable trigger for NET release. NETs, in turn, can stimulate biofilm forma-
tion [97,98]. Thus, a mutual positive feedback mechanism exists here, and mature, stable
biofilms may be surrounded by larger amounts of NETs [98]. Although in the present study
no NETs were visualized, this warrants further assessment in future studies.
Boundary tissues or “locus minoris resistentiae” are often located within avascular
tissues of eye, kidney, joint, heart valves, arteries, and skin where there are reduced or
absent inflammatory responses. As a result, pathogens can colonize and often persist
at these sites [99]. It is interesting to consider the vitreous as a potential locus minoris
resistentiae, with the capillaries of the ciliary body acting as the most likely site of entry
into the vitreous cavity for Leptospira spp. As such, the vitreous body may be thought of as
representing a 28 mL avascular immunological niche [13,39].
5. Conclusions
The clinical signs and chronic disease course of ERU, as well culturable Leptospira spp.
in vitreous samples from these eyes, despite high vitreal antibody titers, apparent immune
evasion, and ineffectiveness of antibiotics, fulfill all the criteria of a biofilm-associated
infection. The previously known steps of biofilm formation have hereby been demon-
strated in vitreous samples from equine eyes suffering from recurrent uveitis using both
Warthin-Starry silver stain and immunohistochemistry. Thus, we conclude that ERU is a
spontaneous disease due to in vivo biofilm formation by Leptospira spp. Future studies
should further differentiate biofilm formation in the equine vitreous, analyze the composi-
tion of this biofilm, and provide insights for other biofilm-associated infections.
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